Exogenous adenosine 5′-triphosphate does not improve survival in rats with acute liver failure

Digestive Diseases and Sciences

Volumn 53, Issue 3, 2008, Pages 794-798

  Becker, Erin P ^a   Sun, Dongfeng ^a   Minuk, Gerald Y ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

31P magnetic resonance spectroscopy; Acute liver failure; Adenosine 5 triphosphate; D galactosamine; Liver

Indexed keywords

ADENOSINE TRIPHOSPHATE; GALACTOSAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; LIVER; LIVER FAILURE; LIVER TOXICITY; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ADENOSINE TRIPHOSPHATE; ANIMALS; LIVER FAILURE, ACUTE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHORUS ISOTOPES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 39849096719     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9940-z     Document Type: Article

References (28)

1. Schiøt FV, Lee WM (2003) Fulminant liver disease. Clin Liver Dis 7:331-349
2. Bernal W, Wendon J (2004) Liver transplantation in adults with acute liver failure. J Hepatol 40:192-197
3. William ML (2003) Acute liver failure in the United States. Liver Dis 23:217-226
4. Schiødt FV, Atillasoy E, Shakil AO et al (1999) Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 5:29-34
5. Ostapowicz G, Fontana R, Schiødt FV, Larson A, Davern T, Han S, McCashland T, Shakil AO, Hay E, Hynan L, Crippin J, Blei A, Samuel G, Reisch J, Lee W U.S. Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann of Int Med 137:947-954
6. Williams R, Gimson AE (1991) Intensive liver care and management of acute hepatic failure. Dig Dis Sci. 36(6):820-826
7. Corbin IR, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY (2003) Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure. J Investig Med 51:42-49
8. Corbin I, Buist R, Peeling J, Zhang M, Uhanova J, Minuk GY (2003) Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease. Gut 52:1046-1053
9. Corbin IR, Buist R, Volotovskyy V, Peeling J, Zhang M, Minuk GY (2002) Examination of regenerative activity and liver function following partial hepatectomy in the rat using P-MR spectroscopy. Hepatology 36:345-353
10. Agteresch HJ, Burgers SA, van der Gaast A, Wilson JH, Dagnelie PC (2003) Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patients. Anticancer Drugs 14:639-644
11. Agteresch HJ, Dagnelie PC, Rietveld T, van den Berg JW, Danser AH, Wilson JH (2000) Pharmacokinetics of intravenous ATP in cancer patients. Eur J Clin Pharmacol 56:49-55
12. Terblanche J, Hickman R (1991) Animal models of fulminant hepatic failure. Dig Dis Sci 36:770-774
13. Muntane J, Rodriguez FJ, Segado O et al (2000) TNF-alpha dependent production of inducibile nitric oxide is involved in PGE (1) protection against acute liver injury. Gut 47:553-562
14. Mourelle M, Meza MA (1989) Colchicine prevents D-galactosamine-induced hepatitis. J Hepatol 8:165-172
15. Keppler D, Lesch R, Reutter W, Decker K (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9:279-290
16. Assy N, Gong Y, Zhang M, Pettigrew NM, Pashniak D, Minuk GY (1998) Use of proliferating cell nuclear antigen as a marker of liver regeneration after partial hepatectomy in rats. J Lab Clin Med 131:251-256
17. Corbin IR, Minuk GY (2003) Serial percutaneous liver biopsies in the laboratory rat. Dig Dis Sci 48:1939-1943
18. Rapaport E, Fontaine J (1989) Generation of extracellular ATP in blood and its mediated inhibition of host weight loss in tumor-bearing mice. Biochem Pharmacol 38:4261-4266
19. Nagy JA (1992) Lymphatic and non lymphatic pathways of peritoneal absorption in mice: physiology versus pathology. Blood Puric 10:148-162
20. Lay CS, Tsai YT, Kong CW, Lee FY, Chang TT, Lin HC, Yang CM, Lee SD, Chiang BN, Lo KJ (1988) The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites. Clin Pharmacol Ther 44:453-457
21. Sass DA, Shakil AO (2003) Fulminant hepatic failure. Gastroenterol Clin North Am 32:1195-1211
22. Cui TX, Iwai M, Hamai M, Minokoshi Y, Shimazu T, Horiuchi M (2000) Aggravation of chemically-induced injury in perfused rat liver by extracellular ATP. Life Sci 66(26) 2593-2601
23. Van de Meer C, Snijders PM, Valkenburg PW (1982) The effect of ATP on survival in intestinal ischemia shock, hemorrhagic shock and endotoxin shock in rats. Circ Shock 9:619-628
24. Lund P, Cornell NW, Krebs HA (1975) Effect of adenosine on the adenine nucleotide content and metabolism of hepatocytes. Biochem J 152:593-599
25. Anghileri LJ, Mayayo E, Domingo JL, Thouvenot P (2002) Toxic and carcinogenic effects of parenteral and percutaneous ATP and its iron complex. Drug Chem Toxicity 25:267-279
26. 31P magnetic resonance spectroscopy study. Hepatology 35:421-424
27. Coutinho-Silva R, Stahl L, Cheung KK, Enes de Campos N, de Oliveira Souza C, Ojcius DM, Burnstock G (2005) P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288:G1024-G1035
28. Thevananther S, Sun H, Li D, Arjunan V, Awad SS, Wyllie S, Zimmerman TL, Goss JA, Karpen SJ (2004) Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 39:393-402